LIDOCAÏNE/PRILOCAÏNE TEVA 5 %, cream tube, 5 g
Active ingredients: Lidocaine, Prilocaine
Commercialized according to BDPMDispensing in France: Prescription only
Creamtube, 5 gcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LIDOCAÏNE/PRILOCAÏNE TEVA 5 %, crème
- Pharmaceutical form
- crème
- Route of administration
- cutanée
- Presentation description
- 1 tube(s) aluminium verni de 5 g avec 2 pansements adhésifs
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Feb 2023
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67973040CIP73000398CIP133400930003985Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LIDOCAÏNEcrème | 25 mg · 1 g de crème | SA |
| PRILOCAÏNEcrème | 25 mg · 1 g de crème | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.